Biotech company in crisis after just one year - candidate failed

Newly-founded ROS Therapeutics' lead candidate showed disappointing pre-clinical results. The company's future now hangs by a thread.

Photo: ROS Therapeutics

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles